Nevanac and Maxidex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nevanac (nepafenac) and Maxidex (dexamethasone). Common drug interactions include cataract among females and choking among males.

The phase IV clinical study analyzes what interactions people have when they take Nevanac and Maxidex. It is created by eHealthMe based on reports of 64 people who take the same drugs from the FDA, and is updated regularly.

What is Nevanac?

Nevanac has active ingredients of nepafenac. It is often used in cataract removal. eHealthMe is studying from 1,755 Nevanac users. Check the latest studies of Nevanac.

What is Maxidex?

Maxidex has active ingredients of dexamethasone. It is often used in high blood pressure. eHealthMe is studying from 1,348 Maxidex users. Check the latest studies of Maxidex.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jun, 14, 2026

64 people who take Nevanac and Maxidex together, and have interactions are studied.

What are the common drug interactions of Nevanac and Maxidex, by gender? *:

female:

Cataract (clouding of the lens inside the eye)
Intraocular pressure increased
Back pain
Eye pain
Vision blurred
Anxiety
Chest pain
Intraocular pressure decreased
Lactic acidosis (low ph in body tissues)
Lung disorder (lung disease)

male:

Choking (mechanical obstruction of the flow of air from the environment into the lungs)
Cough
Stress
Asthma
Malaise (a feeling of general discomfort or uneasiness)
Vomiting
Body temperature decreased
Drug ineffective
Nasopharyngitis (inflammation of the nasopharynx)
Back pain

What are the common drug interactions of Nevanac and Maxidex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Anxiety
Cataract (clouding of the lens inside the eye)
Intraocular pressure decreased
Intraocular pressure increased
Suture rupture
Uveitis (inflammation of the uvea)

40-49:

Ocular hypertension (intraocular pressure higher than normal)
Gastrointestinal pain
Headache (pain in head)
Keratopathy (noninflammatory disease of the cornea)
Suffocation feeling
Tremor (trembling or shaking movements in one or more parts of your body)
Vision blurred

50-59:

Corneal epithelium defect (outer layer defect of cornea)
Eye pain
Intraocular pressure increased
Lacrimation increased
Vision blurred

60+:

Injection site erythema (redness at injection site)
Injection site swelling
Skin disorder (skin disease)
Stress
Asthma
Malaise (a feeling of general discomfort or uneasiness)
Vomiting
Body temperature decreased
Drug ineffective
Nasopharyngitis (inflammation of the nasopharynx)

What are the existing conditions these people have? *

Asthma: 13 people, 20.31%
Osteoporosis (bones weak and more likely to break): 5 people, 7.81%
Cystoid Macular Oedema (fluid accumulation after cataract surgery): 5 people, 7.81%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 4 people, 6.25%
Type 2 Diabetes: 4 people, 6.25%
Glaucoma (increased fluid pressure in the eye with vision loss): 4 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Nevanac and Maxidex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously